Merrimack Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch MACK and buy or sell other stocks, ETFs, and their options commission-free!About MACK
Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310.
CEOGary L. Crocker, MBA
CEOGary L. Crocker, MBA
Employees—
Employees—
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded1993
Founded1993
Employees—
Employees—
MACK Key Statistics
Market cap223.74M
Market cap223.74M
Price-Earnings ratio-8.91
Price-Earnings ratio-8.91
Dividend yield—
Dividend yield—
Average volume515.00K
Average volume515.00K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$15.89
52 Week high$15.89
52 Week low$11.53
52 Week low$11.53
Stock Snapshot
Merrimack Pharmaceuticals(MACK) stock is priced at $15.13, giving the company a market capitalization of 223.74M. It carries a P/E multiple of -8.91.
During the trading day, Merrimack Pharmaceuticals(MACK) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 515K.
Over the past 52 weeks, Merrimack Pharmaceuticals(MACK) stock has traded between a high of $15.89 and a low of $11.53.
Over the past 52 weeks, Merrimack Pharmaceuticals(MACK) stock has traded between a high of $15.89 and a low of $11.53.
People also own
Based on the portfolios of people who own MACK. This list is generated using Robinhood data, and it’s not a recommendation.